EGFR Regulates the Development and Microarchitecture of Intratumoral Angiogenic Vasculature Capable of Sustaining Cancer Cell Intravasation

作者: Petra Minder , Ewa Zajac , James P. Quigley , Elena I. Deryugina

DOI: 10.1016/J.NEO.2015.08.002

关键词:

摘要: Many malignant characteristics of cancer cells are regulated through pathways induced by the tyrosine kinase activity epidermal growth factor receptor (EGFR). Herein, we show that besides directly affecting biology per se, EGFR also regulates primary tumor microenvironment. Specifically, our findings demonstrate both expression and signaling required for induction a distinct intratumoral vasculature capable sustaining cell intravasation, critical rate-limiting step in metastatic cascade. An intravasation-sustaining mode angiogenic vessels depends on high levels interplay between EGFR-regulated production interleukin 8 cells, interleukin-8–induced influx tumor-infiltrating neutrophils delivering their unique matrix metalloproteinase-9, neutrophil metalloproteinase-9–dependent release vascular permeability endothelial factor, VEGF. Our data indicate VEGF-mediated disruption layer integrity increase permeability, significantly facilitates active intravasation cells. Therefore, this study unraveled an important but overlooked function cancer, namely, its ability to create microenvironment within developing orchestrating several interrelated processes initial steps metastasis routes. suggest EGFR-targeted therapies might be more effective when implemented patients with early-staged tumors containing VEGF-dependent vasculature. Accordingly, early inhibition combined various anti-VEGF approaches could synergistically suppress inhibiting highly permeable EGFR-overexpressing aggressive

参考文章(75)
Ronald T. Aimes, Giano Panzarella, Andries Zijlstra, Natalia D. Marchenko, James P. Quigley, John D. Hooper, Rebecca Mellor, A quantitative analysis of rate-limiting steps in the metastatic cascade using human-specific real-time polymerase chain reaction. Cancer Research. ,vol. 62, pp. 7083- 7092 ,(2002)
Harald Janovjak, Patrick Y Muller, André R Miserez, Zuzana Dobbie, Processing of gene expression data generated by quantitative real-time RT-PCR. BioTechniques. ,vol. 32, pp. 1372- 1379 ,(2002)
Gabriele Bergers, Rolf Brekken, Gerald McMahon, Thiennu H. Vu, Takeshi Itoh, Kazuhiko Tamaki, Kazuhiko Tanzawa, Philip Thorpe, Shigeyoshi Itohara, Zena Werb, Douglas Hanahan, Matrix metalloproteinase-9 triggers the angiogenic switch during carcinogenesis Nature Cell Biology. ,vol. 2, pp. 737- 744 ,(2000) , 10.1038/35036374
Helena A. Yu, Gregory J. Riely, Second-generation epidermal growth factor receptor tyrosine kinase inhibitors in lung cancers. Journal of The National Comprehensive Cancer Network. ,vol. 11, pp. 161- 169 ,(2013) , 10.6004/JNCCN.2013.0024
Erin M. Bekes, Elena I. Deryugina, Tatyana A. Kupriyanova, Ewa Zajac, Kenneth A. Botkjaer, Peter A. Andreasen, James P. Quigley, Activation of Pro-uPA Is Critical for Initial Escape from the Primary Tumor and Hematogenous Dissemination of Human Carcinoma Cells Neoplasia. ,vol. 13, pp. 806- 821 ,(2011) , 10.1593/NEO.11704
L. Ossowski, E. Reich, Experimental Model for Quantitative Study of Metastasis Cancer Research. ,vol. 40, pp. 2300- 2309 ,(1980)
H. Nozawa, C. Chiu, D. Hanahan, Infiltrating neutrophils mediate the initial angiogenic switch in a mouse model of multistage carcinogenesis Proceedings of the National Academy of Sciences of the United States of America. ,vol. 103, pp. 12493- 12498 ,(2006) , 10.1073/PNAS.0601807103
C. Cripps, E. Winquist, M. C. Devries, D. Stys-Norman, R. Gilbert, Epidermal growth factor receptor targeted therapy in stages III and IV head and neck cancer. Current Oncology. ,vol. 17, pp. 37- 48 ,(2010) , 10.3747/CO.V17I3.520
Elena I. Deryugina, Andries Zijlstra, Juneth J. Partridge, Tatyana A. Kupriyanova, Mark A. Madsen, Thales Papagiannakopoulos, James P. Quigley, Unexpected Effect of Matrix Metalloproteinase Down-Regulation on Vascular Intravasation and Metastasis of Human Fibrosarcoma Cells Selected In vivo for High Rates of Dissemination Cancer Research. ,vol. 65, pp. 10959- 10969 ,(2005) , 10.1158/0008-5472.CAN-05-2228